血液公司
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionCalvert Variable Products, Inc. - Calvert VP S&P MidCap 400 Index Portfolio - I Class
Latest Disclosed Ownership9,754 shares
Latest Disclosed Value $ 727,745
Calvert Variable Products, Inc. - Calvert VP S&P MidCap 400 Index Portfolio - I Class reports 3.04% decrease in ownership of HAE / Haemonetics Corporation

On August 25, 2025 - Calvert Variable Products, Inc. - Calvert VP S&P MidCap 400 Index Portfolio - I Class filed a NPORT-P form disclosing ownership of 9,754 shares of Haemonetics Corporation (US:HAE) valued at $727,746 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 10,060 shares of Haemonetics Corporation. This represents a change in shares of -3.04% during the quarter. The current value of the position is $681,317 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-25 2025-06-30 NP Haemonetics EC US4050241003 9,754 -306 -3.04 728 13.77 0.1232
2025-05-28 2025-03-31 NP Haemonetics EC US4050241003 10,060 0 0.00 639 -18.60 0.1143
2025-02-19 2024-12-31 NP Haemonetics EC US4050241003 10,060 -440 -4.19 785 -6.88 0.1294
2024-11-27 2024-09-30 NP Haemonetics EC US4050241003 10,500 -302 -2.80 844 -5.60 0.1368
2024-08-20 2024-06-30 NP Haemonetics EC US4050241003 10,802 -402 -3.59 894 -6.59 0.1512
2024-05-28 2024-03-31 NP Haemonetics EC US4050241003 11,204 0 0.00 956 -0.21 0.1536
2024-02-02 2023-12-31 NP Haemonetics EC US4050241003 11,204 -169 -1.49 958 -5.89 0.1658
2023-11-29 2023-09-30 NP Haemonetics EC US4050241003 11,373 -1,225 -9.72 1,019 -5.04 0.1948
2023-08-22 2023-06-30 NP Haemonetics EC US4050241003 12,598 -245 -1.91 1,073 0.94 0.1835
2023-05-26 2023-03-31 NP Haemonetics EC US4050241003 12,843 -354 -2.68 1,063 2.41 0.1886
2023-03-01 2022-12-31 NP Haemonetics EC US4050241003 13,197 0 0.00 1,038 6.25 0.1872
2022-11-28 2022-09-30 NP Haemonetics EC US4050241003 13,197 -303 -2.24 977 11.04 0.1928
2022-08-22 2022-06-30 NP Haemonetics EC US4050241003 13,500 0 0.00 880 3.05 0.1650
2022-05-27 2022-03-31 NP Haemonetics EC US4050241003 13,500 0 0.00 853 19.13 0.1343
2022-02-28 2021-12-31 NP Haemonetics EC US4050241003 13,500 0 0.00 716 -24.79 0.1050
2021-11-24 2021-09-30 NP Haemonetics EC US4050241003 13,500 -533 -3.80 953 1.82 0.1494
2021-08-19 2021-06-30 NP Haemonetics EC US4050241003 14,033 0 0.00 935 -39.95 0.1427
2021-05-28 2021-03-31 NP Haemonetics EC US4050241003 14,033 0 0.00 1,558 -6.54 0.2424
2021-02-16 2020-12-31 NP Haemonetics EC US4050241003 14,033 -320 -2.23 1,666 33.07 0.2849
2020-11-25 2020-09-30 NP Haemonetics EC US4050241003 14,353 -224 -1.54 1,252 -4.06 0.2587
2020-08-24 2020-06-30 NP Haemonetics EC US4050241003 14,577 362 2.55 1,306 -7.84 0.2759
2020-05-29 2020-03-31 NP Haemonetics EC US4050241003 14,215 0 0.00 1,417 -13.29 0.3863
2020-02-24 2019-12-31 NP Haemonetics EC 405024100 14,215 -135 -0.94 1,633 -9.78 0.3074
2019-11-27 2019-09-30 NP Haemonetics EC US4050241003 14,350 14,350 1,810 0.3593
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.